Stay updated on Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.

Latest updates to the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check75 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and has removed the date 2025-03-25.SummaryDifference0.7%
Stay in the know with updates to Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.